Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 4

00:08 EST 23rd December 2014 | BioPortfolio

Drug Discovery News - Page: 4Twitter RSS

Read the latest Drug Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Drug Discovery.

Search or Follow Our Drug Discovery - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Drug Discovery - Page: 4 News.
You can also follow our Drug Discovery - Page: 4 news stories on Twitter: @DiscoveryDrug

Showing "drug drug discovery discovery" News Articles 76 to 100 of 27,000+

Monday 22nd December 2014

BioCryst's Rapivab receives FDA approval to treat aAcute uncomplicated influenza

BioCryst Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved RAPIVAB (peramivir injection), an intravenous (i.v.) neuraminidase inhibitor for the treatment of acute uncomplicated influenza in patients 18 years ...

Express Scripts To Cover AbbVie's Newly Approved Hepatitis C Drug

COOL VALLEY (dpa-AFX) - Pharmacy benefits manager Express Scripts Holding Co. (ESRX) announced Monday it will add drug maker AbbVie Inc.'s (ABBV) newly approved Viekira Pak, a breakthrough treatme...

FDA clears AbbVie's hepatitis C regimen Viekira Pak

AbbVie is celebrating after the US FDA approved its all-oral hepatitis C regimen Viekira Pak, which has been tipped by analysts to achieve peak sales of around $3 billion.The regimen consists of Viekira (ombitasvir/paritaprevir/ritonavir) along with ...

Bio-Path Holdings to Initiate Development of Liposomal Bcl-2 in Follicular Lymphoma

Company Broadening its Pipeline with Second Product Candidate Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has initiated development of Liposomal Bcl-2 as a treatment for follicular lymphoma. Bio-Path has a completed pre...

Cerus Reports US Phase 2 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint

Cerus Corporation (NASDAQ:CERS) announced today that its Phase 2 clinical trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated red blood cells continued to circulate 24 hours following transfusion. The investigators plan to submit data from...

Simulations Plus to Present at the Sidoti & Company Emerging Growth Institutional Investor Forum on January 12, 2015

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Dr. Ted Grasela, President, will present at the Sidoti & Company, LLC, Emerging Growth Institutional Investor Forum on January 12, 2015. The conference will be held at the Grand Hyatt Hotel in M...

CfPIE Announces Partnership with the Society for Clinical Data Management

Partnership extends affordable training and certification to professionals in the clinical data management and pharmaceutical/clinical trials industries Malvern, PA & Brussels (PRWEB) December 22, 2014 The Center for Professional Innovation and Education (CfPIE), the global leader of technical training across the life sciences industry, has partnered with the Society for Clinical Data Managem...

Bone loss drug may help stave off endometrial cancer

Women who use bisphosphonates – drugs that treat osteoporosis and other bone conditions – seem to have about half the risk of developing endometrial cancer as women who do not use the drugs, according to findings in Cancer. Previous research has found that bisphosphonates reduce the likelihood of some forms of cancer; the new study […]

Teva to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Goldman Sachs Healthcare CEOs Unscripted Conference. Erez Vigodman, President & CEO will present on Tuesday, January 6, 2015 at 10:15 AM EST.     ...

FDA approves Jazz’s intravenous administration of Erwinaze

The US Food and Drug Administration (FDA) has issued approval for the Jazz Pharmaceuticals' intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi).

Lilly to market stomach cancer drug in Europe

Eli Lilly has been granted permission by the European Commission to market Cyramza in Europe. Lilly's Cyramza (ramucirumab) is the first licensed drug specifically indicated for adults with recurrent advanced stomach cancer, or gastro-oesophageal junction adenocarcinoma, who have had chemotherapy (with fluoropyrimidine and platinum). Cyramza works by binding to a receptor that blocks a key pathway...

Express Scripts, AbbVie Enter Multi-Year Deal For Access To Hepatitis C Drug

COOL VALLEY (dpa-AFX) - Express Scripts (ESRX) announced an update to its National Preferred Formulary that will significantly expand access to AbbVie's (ABBV) new medication, Viekira Pak, a break...

FDA approves Rapivab to treat flu infection

On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults.

Lilly’s Cyramza approved in EU for stomach cancer

The European Commission has granted marketing authorisation (MA) for Eli Lilly's ramucirumab (Cyramza) in stomach cancer, making it the first therapy approved for second-line advanced stomach and gastro-oesophageal junction (GOJ) cancer in the region...

Scripps Research Institute Scientists Uncover New, Fundamental Mechanism for How Resveratrol Provides Health Benefits

LA JOLLA, Calif. and JUPITER, Fla., Dec. 22, 2014 /PRNewswire-USNewswire/ -- Scientists at The Scripps Research Institute (TSRI) have found that resveratrol, the red-wine ingredient once touted as an elixir of youth, powerfully activates an evolutionarily ancient stress response in human cells. The finding should dispel much of the mystery and controversy about how resveratrol really works. "This...

Roche ends Phase III trial of gantenerumab in prodromal Alzheimer’s disease

Swiss drug major Roche is to end the Phase III study of experimental anti-amyloid drug gantenerumab in prodromal Alzheimer’s disease.

FDA approves BioCryst's intravenous flu drug

(Reuters) - The U.S. Food and Drug Administration approved Biocryst Pharmaceuticals Inc's intravenous flu drug, sending the company's shares up nearly 10 percent in premarket trading.

Cardiome links with Eddingpharm for Brinavess in China

Canadian drugmaker Cardiome Pharma has entered into an agreement with Chinese firm Eddingpharm to develop and commercialize Brinavess (vernakalant intravenous) in China, Taiwan, and Macau and re-launch the drug in Hong Kong.

Tiziana licenses anti-inflammatory foralumab from Novimmune

Oncology and immunology specialist Tiziana and antibody-based drug manufacturer Novimmune have entered into an agreement whereby Novimmune grants Tiziana an exclusive license for the clinical development and commercialization of foralumab.

Clarithromycin-statin mix can cause drug interactions, requiring hospitalization

The combination of the common antibiotic clarithromycin with some statins increases the risk of adverse events, which may require hospital admission for older people, according to a new study published in CMAJ (Canadian Medical Association Journal).

UPDATE 1-FDA approves BioCryst's intravenous flu drug

Dec 22 (Reuters) - The U.S. Food and Drug Administration approved Biocryst Pharmaceuticals Inc's intravenous flu drug, sending the company's shares up nearly 10 percent in premarket trading.

Capital BlueCross provides funding to enable municipal police to carry lifesaving drug for people who overdose

HARRISBURG, Pa., Dec. 22, 2014 /PRNewswire/ -- Capital BlueCross today announced that the company is providing funding to enable municipal police departments in its service area to purchase and carry naloxone, a prescription drug that can help save the life of a person who has overdosed on prescription painkillers or heroin. The Pennsylvania District Attorneys Association will administer the init...

Monday’s most followed in U.S. including Express Scripts, Gilead, Cubist, American Apparel, Staples, Caesars Entertainment, AMC Networks, TerraForm, Ocwen, Boeing

U.S. shares wavered as gains in technology companies outstripped the first decline in five days for energy producers. The S&P 500 (INDEXSP:.INX) edged up 0.1 percent at 11:33 a.m. in New York. The 30-company Dow Jones Industrial Average (INDEXDJX...

Roche Alzheimer and Breast Cancer Drugs Hit Snags

Swiss pharmaceutical producer group Roche said it would discontinue a late-stage study of investigational anti-amyloid medicine gantenerumab in pre-dementia Alzheimer's disease, following a pre-planned futility analysis and recommendation by the inde...

Sevion Announces Antibody Discovery Collaboration with Johnson & Johnson Innovation and Janssen

Sevion Therapeutics Inc. ("Sevion" or the "Company") (OTCQB:SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics, today announced a collaboration agreement with CNA Development, LLC, an affiliate of Janssen Pharmaceuticals, Inc. (Janssen) to discover antibodies using Sevion’s spatially addressed library plat...

Search BioPortfolio:

News Quicklinks